CID 58441401

Cnx-1351

Structural Information

Molecular Formula
C30H35N7O3S
SMILES
CC(=CC(=O)CCC(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6)C
InChI
InChI=1S/C30H35N7O3S/c1-20(2)16-21(38)6-7-27(39)36-10-8-35(9-11-36)19-22-17-26-28(41-22)30(37-12-14-40-15-13-37)33-29(32-26)23-4-3-5-25-24(23)18-31-34-25/h3-5,16-18H,6-15,19H2,1-2H3,(H,31,34)
InChIKey
DLNUPKDFXMWRFP-UHFFFAOYSA-N
Compound name
1-[4-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-6-methylhept-5-ene-1,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

2
References

85
Patents

573.2522 Da
Monoisotopic Mass

2.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 574.25948 232.3
[M+Na]+ 596.24142 236.7
[M-H]- 572.24492 237.0
[M+NH4]+ 591.28602 230.0
[M+K]+ 612.21536 229.5
[M+H-H2O]+ 556.24946 221.2
[M+HCOO]- 618.25040 231.6
[M+CH3COO]- 632.26605 235.0
[M+Na-2H]- 594.22687 224.0
[M]+ 573.25165 232.1
[M]- 573.25275 232.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe